Portfolio News

FDA Biomarker—John Wagner

Koneksa Health Chief Medical Officer John A. Wagner, MD, Ph.D., recently gave a video presentation titled “Multi-Component Biomarkers: Promise, Practice and Perspective on Terminology,” which was uploaded to the U.S. Food and Drug Administration’s YouTube channel. Dr. Wagner began with a general introduction to biomarkers. A biomarker is a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or biological responses to an exposure or intervention, including therapeutic interventions. Some biomarkers that will be familiar even to people without a strong...

How Digital Engagement with Patients Leads to Better Quality Care with Mike McSherry of Xealth

In an episode of the This Week in Health IT podcast, Bill Russell and Xealth CEO Mike McSherry discussed how digital engagement with patients leads to better quality care experiences and outcomes. They also discuss what digital health means for patient education, decision making and the quality of the care experience. McSherry says Xealth’s definition of digital health is different from a more traditional understanding of the field. He says that Xealth’s definition of digital health encompasses everything from apps managing behavioral health and chronic illnesses,...

Best Places to Work 2022

Glassdoor, a provider of insights about companies and jobs, recently announced its list of the best small to medium businesses in the United States to work in the coming year. Taking the 45th spot on this list is primary care support company Aledade. Aledade has a Glassdoor rating of 4.5/5 stars, according to 141 employee reviews. With its stated mission to help people everywhere find a job and company they love, Glassdoor focuses its lists on improving transparency in the workplace. It collects millions of company...

Announcing our latest investment led by Spectrum Equity and McKesson Ventures

RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture Partners, and dRx Capital. RxVantage’s goal is to promote technology that allows professionals in healthcare and life science to collaborate seamlessly, safely, and effectively. Its technology allows medical practices to get important resources, wherever and whenever they are needed. The new investment is following a time of notable growth for...

MM+M Podcast 1.18.22: Digital health’s funding frenzy (and what it means)

Rock Health Head of Consulting Sari Kaganoff appeared on the MM+M (Medical, Marketing + Media) podcast to unpack the numbers and interpret the directional signs behind last year’s frenzied funding environment for digital health. She said 2021 was a big year for digital health, noting that $29.1 billion was raised by venture-backed startups, according to Rock Health data. This is almost twice the prior year and much higher than years before that. The average deal size increased very notably for series D and above, Kaganoff said....